Stock Research: West Pharmaceutical Services

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

West Pharmaceutical Services

NYSE:WST US9553061055
93
  • Value
    52
  • Growth
    37
  • Safety
    Safety
    100
  • Combined
    90
  • Sentiment
    95
  • 360° View
    360° View
    93
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

West Pharmaceutical Services, Inc. designs and manufactures containment and delivery systems for injectable drugs. The company operates in the pharmaceutical, diagnostic, and medical device industries. It is a global company. In the last fiscal year, the company had a market cap of $15,881 million, profits of $1 million, and revenue of $3 million, with 10600 employees.

more
Index
Dividends USA
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 48 26 57
Growth
37 12 65 81
Safety
Safety
100 100 93 85
Sentiment
95 56 86 93
360° View
360° View
93 76 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
63 78 67 36
Opinions Change
65 7 50 91
Pro Holdings
n/a 47 69 69
Market Pulse
80 71 87 72
Sentiment
95 56 86 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 48 26 57
Growth
37 12 65 81
Safety Safety
100 100 93 85
Combined
90 44 73 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
24 18 18 24
Price vs. Earnings (P/E)
27 31 13 31
Price vs. Book (P/B)
22 23 9 14
Dividend Yield
87 84 79 86
Value
52 48 26 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
53 54 63 37
Profit Growth
54 18 42 86
Capital Growth
16 9 12 39
Stock Returns
35 22 93 83
Growth
37 12 65 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
77 72 64 58
Refinancing
34 20 25 25
Liquidity
100 100 100 98
Safety Safety
100 100 93 85

Similar Stocks

Discover high‑ranked alternatives to West Pharmaceutical Services and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: